A new MRSA test that helps you detect recently emerged strains has earned the Food and Drug Administration’s market approval, says manufacturer BD Diagnostics.
The BD MAX MRSA XT Assay is the company’s second test that can detect MRSA strains with the mecC gene, but the first that can do so via a nasal swab. The earlier version, released in 2013, could be used only on patients about to undergo surgery.
{iframe}http://www.outpatientsurgery.net/newsletter/eweekly/2014/01/21/new-mrsa-test-gets-fda-nod{/iframe}